Atom Investors’s ClearPoint Neuro CLPT Stock Holding History

Atom Investors’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-23,899	Closed	-$456K	–	327
2021 Q2	$456K	Buy	+23,899	New	+$462K	0.06%	169

Other funds holding CLPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GPC

Guardian Point Capital Charlottesville, Virginia $243M AUM 22.43% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

TFCM

Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

PGM

Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return

Atom Investors's CLPT Position: Q3 2021 in Review

Atom Investors sold out of ClearPoint Neuro (CLPT) in Q3 2021, closing a stake of 23,899 shares — an estimated $456K sold.

Atom Investors first reported a position in CLPT in Q2 2021 and held it in 1 quarter. The position peaked at $456K in Q2 2021. 69 funds tracked by Wall St. Rank hold CLPT as of Q3 2021.

Atom Investors reported no remaining ClearPoint Neuro position as of Q3 2021 after selling out during the quarter.
Atom Investors sold 23,899 ClearPoint Neuro shares in Q3 2021, an estimated $456K.
Atom Investors first reported a position in ClearPoint Neuro in Q2 2021 and held it in 1 quarter.
Atom Investors's ClearPoint Neuro position peaked at $456K in Q2 2021.
69 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q3 2021.

Based on Atom Investors's 13F filing for Q3 2021, filed 15 Nov 2021.